News

Prime Healthcare, EmVenio Research and Health Wizz Announce Strategic Partnership and Launch of EmVenio Research Center at Prime Healthcare EmVenio Research announces an exclusive partnership with Prime Healthcare and Health

Advancements in Decentralized Clinical Trials: The Impact of AI on Mobile Visits View our on-demand webinar now! In March 2024, the US FDA issued its guidance, “Artificial Intelligence & Medical

Quality in Motion: Meet Our Mobile Clinicians: Nikki Degreeff Meet Nikki Degreeff, a Clinical Project Manager who began her journey with PCM Trials as a Certified Mobile Research Nurse (CMRN).

The Denver Business Journal details our recent acquisition of Emvenio Research, and our second acquisition of 2024.

In partnership with GlobalData, PCM Trials recently hosted a live webinar that offered a look into the evolution and future of decentralized clinical trials (DCTs).

Denver (February 23, 2024) – Denver-based PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials (DCTs), today announced the acquisition of EmVenio Research based in Durham, North Carolina.

PCM Trials expands its global footprint PCM Trials President Greg Austin spoke with the Denver Business Journal last week about the company’s recent acquisition of Netherlands-based Clinical Trial Service (CTS).

Denver (January 10, 2024) – PCM Trials, a Denver, USA-based leader in providing mobile research nurses for decentralized clinical trials, today announced the acquisition of Clinical Trial Service (CTS).

On November 14, 2023, industry experts from PCM Trials were joined by trusted logistics vendors for a live webinar featuring lively conversation about overcoming challenges to successfully deliver compliant mobile visits around the world.

The clinical trial industry is literally exploding, launching more trials within shorter windows, adding new players, incorporating new technologies and meeting unprecedented regulatory challenges.